These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 22647889

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Dalsgaard M, Bang CN, Egstrup K, Ray S, Boman K, Rossebø AB, Gohlke-Baerwolf C, Devereux RB, Køber L, Wachtell K.
    Stroke; 2014 Jul; 45(7):1939-46. PubMed ID: 24903982
    [Abstract] [Full Text] [Related]

  • 25. Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).
    Bang CN, Greve AM, La Cour M, Boman K, Gohlke-Bärwolf C, Ray S, Pedersen T, Rossebø A, Okin PM, Devereux RB, Wachtell K.
    Am J Cardiol; 2015 Dec 15; 116(12):1840-4. PubMed ID: 26602073
    [Abstract] [Full Text] [Related]

  • 26. Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS).
    Nielsen OW, Sajadieh A, Sabbah M, Greve AM, Olsen MH, Boman K, Nienaber CA, Kesäniemi YA, Pedersen TR, Willenheimer R, Wachtell K.
    Circulation; 2016 Aug 09; 134(6):455-68. PubMed ID: 27486164
    [Abstract] [Full Text] [Related]

  • 27. Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: a SEAS substudy.
    Bahlmann E, Cramariuc D, Gerdts E, Gohlke-Baerwolf C, Nienaber CA, Eriksen E, Wachtell K, Chambers J, Kuck KH, Ray S.
    JACC Cardiovasc Imaging; 2010 Jun 09; 3(6):555-62. PubMed ID: 20541709
    [Abstract] [Full Text] [Related]

  • 28. Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: a SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis).
    Rogge BP, Cramariuc D, Lønnebakken MT, Gohlke-Bärwolf C, Chambers JB, Boman K, Gerdts E.
    J Am Coll Cardiol; 2013 Oct 29; 62(18):1683-1690. PubMed ID: 23770175
    [Abstract] [Full Text] [Related]

  • 29. Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.
    Green A, Ramey DR, Emneus M, Iachina M, Stavem K, Bolin K, McNally R, Busch-Sørensen M, Willenheimer R, Egstrup K, Kesäniemi YA, Ray S, Basta N, Kent C, Pedersen TR.
    Am J Cardiol; 2014 Nov 15; 114(10):1518-22. PubMed ID: 25267716
    [Abstract] [Full Text] [Related]

  • 30. Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications.
    Bahlmann E, Cramariuc D, Minners J, Lønnebakken MT, Ray S, Gohlke-Baerwolf C, Nienaber CA, Jander N, Seifert R, Chambers JB, Kuck KH, Gerdts E.
    Eur Heart J Cardiovasc Imaging; 2017 Apr 01; 18(4):404-412. PubMed ID: 27491438
    [Abstract] [Full Text] [Related]

  • 31. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN, Gerdts E, Aurigemma GP, Boman K, de Simone G, Dahlöf B, Køber L, Wachtell K, Devereux RB.
    Circ Cardiovasc Imaging; 2014 May 01; 7(3):422-9. PubMed ID: 24723582
    [Abstract] [Full Text] [Related]

  • 32. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).
    Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlöf B, Devereux RB.
    Eur J Echocardiogr; 2008 Nov 01; 9(6):809-15. PubMed ID: 18490279
    [Abstract] [Full Text] [Related]

  • 33. Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K.
    Int J Cardiol; 2013 Jun 05; 166(1):72-6. PubMed ID: 21996417
    [Abstract] [Full Text] [Related]

  • 34. Lower Transaortic Flow Rate Is Associated With Increased Mortality in Aortic Valve Stenosis.
    Saeed S, Senior R, Chahal NS, Lønnebakken MT, Chambers JB, Bahlmann E, Gerdts E.
    JACC Cardiovasc Imaging; 2017 Aug 05; 10(8):912-920. PubMed ID: 28797414
    [Abstract] [Full Text] [Related]

  • 35. Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events.
    Bang CN, Greve AM, Rossebø AB, Ray S, Egstrup K, Boman K, Nienaber C, Okin PM, Devereux RB, Wachtell K.
    J Am Heart Assoc; 2017 Nov 27; 6(12):. PubMed ID: 29180457
    [Abstract] [Full Text] [Related]

  • 36. Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study.
    Gohlke-Bärwolf C, Minners J, Jander N, Gerdts E, Wachtell K, Ray S, Pedersen TR.
    Curr Probl Cardiol; 2013 Sep 27; 38(9):365-409. PubMed ID: 23972937
    [Abstract] [Full Text] [Related]

  • 37. Impact of Obesity on Persistent Left Ventricular Hypertrophy After Aortic Valve Replacement for Aortic Stenosis.
    Einarsen E, Saeed S, Cramariuc D, Chambers JB, Midtbø H, Gerdts E.
    Am J Cardiol; 2019 Mar 15; 123(6):942-947. PubMed ID: 30654925
    [Abstract] [Full Text] [Related]

  • 38. Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF.
    Jander N, Hochholzer W, Kaufmann BA, Bahlmann E, Gerdts E, Boman K, Chambers JB, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Wachtell K, Gohlke-Bärwolf C, Neumann FJ, Minners J.
    Heart; 2014 Dec 15; 100(24):1946-53. PubMed ID: 25217488
    [Abstract] [Full Text] [Related]

  • 39. Sex differences in cardiovascular outcome during progression of aortic valve stenosis.
    Cramariuc D, Rogge BP, Lønnebakken MT, Boman K, Bahlmann E, Gohlke-Bärwolf C, Chambers JB, Pedersen TR, Gerdts E.
    Heart; 2015 Feb 15; 101(3):209-14. PubMed ID: 25301859
    [Abstract] [Full Text] [Related]

  • 40. Effect of simvastatin and ezetimibe on suPAR levels and outcomes.
    Hodges GW, Bang CN, Forman JL, Olsen MH, Boman K, Ray S, Kesäniemi YA, Eugen-Olsen J, Greve AM, Jeppesen JL, Wachtell K.
    Atherosclerosis; 2018 May 15; 272():129-136. PubMed ID: 29602140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.